LifeMD, Inc. (LFMD)
- Sector
- Healthcare
- Industry
- Health Information Services
- Last price
- $2.37
- As of
Kresmion compiles this page from LFMD's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
LifeMD, Inc. (LFMD): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-15.
See the full LFMD dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for LFMD on one page. Preview it with sample data, then open it live with a free account.
Preview the LFMD dossierActive signals for LFMD
- mediumEARNINGS_MISS
Q2-2026: Missed consensus by 7.7%, EPS $-0.16 vs $-0.1486 estimate
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +70% to LFMD (2026Q2)
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +85% to LFMD (2026Q2)
- highINSTITUTIONAL_EXIT
D. E. Shaw & Co., Inc. cut 89% of LFMD (2026Q2)
- lowEARNINGS_MISS
Q4-2025: EPS $-0.04 vs $-0.034 estimate, -0.01 on a near-zero consensus
FREE, NO ACCOUNT
Every signal on LFMD, as it fires
You are seeing 5 of 9 signals recorded on LFMD since 2026-06-05.
The five above landed across 3 days. The other 4 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in LFMD (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 53216B104 · 2026Q2 | $4.5M | 0.01% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 53216B104 · 2026Q2 | $1.7M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 53216B104 · 2026Q2 | $1.1M | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 53216B104 · 2026Q2 | $136K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, LFMD
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
LFMD against its peers
LFMD's operating margin of -4.0% ranks in the 58th percentile of 17 Health Information Services sub-industry peers, fiscal periods ending between 2025-10-31 and 2026-01-31.
| Metric | LFMD | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 194M USD | 99.3M USD | 68 | 16 |
| Gross margin | 85.7% | 59.0% | 95 | 10 |
| Operating margin | -4.0% | -12.8% | 58 | 17 |
| Net margin | 7.4% | -15.9% | 86 | 17 |
| Return on equity | 62.0% | -30.0% | 92 | 17 |
| P / E | 9.5x | 28.9x | 25 | 5 |
| 1 year | -62.7% | -37.7% | 23 | 14 |
Peers (19): HCAT, RVRC, CCLD, OPRX, AMWL, DRIO, VASO, SY, CARL, TBRG, ONMD, NRC, BEAT, WEAV, SOPH, PHR, CRVW, BFRG, PBSV. Left out: HYDTF (no annual filing), RNLXY (period gap), VRHI (no annual filing), DGNOF (no annual filing), RMHI (no annual filing), OHCFF (no annual filing). Fiscal periods ending between 2025-10-31 and 2026-01-31. Every figure is one full fiscal year read from one annual filing (LFMD: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow LFMD on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to LFMD for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.